Free Trial
NASDAQ:SCNX

Scienture (SCNX) Stock Price, News & Analysis

Scienture logo
$0.83 -0.03 (-3.01%)
Closing price 04:00 PM Eastern
Extended Trading
$0.83 +0.00 (+0.19%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Scienture Stock (NASDAQ:SCNX)

Advanced

Key Stats

Today's Range
$0.82
$0.87
50-Day Range
$0.86
$2.39
52-Week Range
$0.69
$9.55
Volume
136,896 shs
Average Volume
1.12 million shs
Market Capitalization
$17.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Scienture Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

SCNX MarketRank™: 

Scienture scored higher than 18% of companies evaluated by MarketBeat, and ranked 911th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Scienture.

  • Percentage of Shares Shorted

    1.22% of the float of Scienture has been sold short.
  • Short Interest Ratio / Days to Cover

    Scienture has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Scienture does not currently pay a dividend.

  • Dividend Growth

    Scienture does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.22% of the float of Scienture has been sold short.
  • Short Interest Ratio / Days to Cover

    Scienture has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Sentiment

    Scienture has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Scienture this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Scienture to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Scienture insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    49.70% of the stock of Scienture is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.68% of the stock of Scienture is held by institutions.

  • Read more about Scienture's insider trading history.
Receive SCNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scienture and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SCNX Stock News Headlines

Scienture Holdings Enters Equity Distribution Agreement
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
See More Headlines

SCNX Stock Analysis - Frequently Asked Questions

Scienture's stock was trading at $6.05 at the beginning of the year. Since then, SCNX stock has decreased by 86.3% and is now trading at $0.83.

Scienture Holdings, Inc. (NASDAQ:SCNX) announced its earnings results on Tuesday, August, 12th. The company reported ($0.48) earnings per share for the quarter. Scienture had a negative net margin of 10,364.22% and a negative trailing twelve-month return on equity of 24.47%.

Shares of SCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scienture investors own include Cogent Communications (CCOI), Cavco Industries (CVCO), Liberty Broadband (LBRDK), Liberty Global (LBTYB), PayPal (PYPL), Roku (ROKU) and Arch Capital Group (ACGL).

Company Calendar

Last Earnings
8/12/2025
Today
9/25/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Wholesale
Current Symbol
NASDAQ:SCNX
CIK
1382574
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$9.07 million
Net Margins
-10,364.22%
Pretax Margin
-15,853.78%
Return on Equity
-24.47%
Return on Assets
-19.30%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
0.11
Quick Ratio
0.11

Sales & Book Value

Annual Sales
$128.20 thousand
Price / Sales
134.35
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.04 per share
Price / Book
0.09

Miscellaneous

Outstanding Shares
20,751,000
Free Float
10,438,000
Market Cap
$17.22 million
Optionable
N/A
Beta
3.06
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:SCNX) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners